Intrathecal Somatostatin in Terminally Ill Patients. A Report of Two Cases
Overview
Authors
Affiliations
Intrathecal morphine has been shown to be reliable in producing analgesia in patients with intractable cancer pain. Recently, we have demonstrated that intrathecal somatostatin is as effective in the treatment of cancer pain as intrathecal morphine. This report presents 2 cases in whom analgesia could be maintained for 60 and 25 days, respectively, under continuous intrathecal infusion of somatostatin by means of infusion devices.
Jung S, Jo S, Lee S, Oh E, Kim M, Nam W Korean J Physiol Pharmacol. 2009; 12(5):253-8.
PMID: 19967064 PMC: 2788644. DOI: 10.4196/kjpp.2008.12.5.253.
Donner B, Tryba M, Zenz M, Strumpf M Schmerz. 1994; 8(2):71-81.
PMID: 18415440 DOI: 10.1007/BF02530412.
Pharmacotherapy: non-serotonergic mechanisms.
Spiller R Gut. 2002; 51 Suppl 1:i87-90.
PMID: 12077075 PMC: 1867722. DOI: 10.1136/gut.51.suppl_1.i87.
Grabow T, Derdzinski D, Staats P Curr Pain Headache Rep. 2001; 5(6):510-6.
PMID: 11676885 DOI: 10.1007/s11916-001-0068-0.
Tonic control of peripheral cutaneous nociceptors by somatostatin receptors.
Carlton S, Du J, Zhou S, Coggeshall R J Neurosci. 2001; 21(11):4042-9.
PMID: 11356891 PMC: 6762714.